z-logo
Premium
Recent increase in allergic reactions to methylchloroisothiazolinone/methylisothiazolinone: is methylisothiazolinone the culprit?
Author(s) -
Geier Johannes,
Lessmann Holger,
Schnuch Axel,
Uter Wolfgang
Publication year - 2012
Publication title -
contact dermatitis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.524
H-Index - 96
eISSN - 1600-0536
pISSN - 0105-1873
DOI - 10.1111/j.1600-0536.2012.02157.x
Subject(s) - culprit , medicine , dermatology , sensitization , allergic contact dermatitis , cosmetics , contact dermatitis , concomitant , preservative , allergy , pathology , immunology , myocardial infarction , chemistry , food science
Background. The frequency of sensitization to methylchloroisothiazolinone (MCI)/ methylisothiazolinone (MI) observed in the Information Network of Departments of Dermatology (IVDK) was constantly around 2.1% from 1998 to 2009. After that, it increased to 3.9% in 2011, paralleled by an increase in the frequency of allergic reactions to MI in the preservative series from 1.9% in 2009 to 4.4% in 2011. MI without MCI has increasingly been used as a preservative in cosmetics and skin care products in recent years. Objectives. To epidemiologically investigate the possible reasons for this development and to analyse concomitant reactions to MCI/MI and MI. Methods. A retrospective analysis of IVDK data from 2009 to 2011 was performed. Results. Stratified data analysis revealed pronounced increases in reactivity to MCI/MI and MI in females, face dermatitis patients, and patients tested because of suspected cosmetic intolerance. The proportion of MI‐positive patients among those reacting to MCI/MI increased from 43% to 59% between 2009 and 2011. Conclusion. More widespread consumer exposure has most likely led to the increase in primary sensitization to MI and subsequently to a rise in MCI/MI reactions resulting from immunological cross‐reactions. A reduction in the maximum use concentration of MI seems advisable. MI should be patch tested in the baseline series.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here